Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot Study

NCT05723406 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05723406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05723406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot Study
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
March 21, 2023
Completion date
November 23, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

innate inflammatory response, osteoarthritis, hip